Skip to content

Barrier protection to lower transmission and infection rates with Gram-negative bacteria in preterm children

Barrier protection to lower transmission and infection rates with Gram-negative bacteria in preterm children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00019103
Enrollment
12
Registered
2020-01-16
Start date
2020-10-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonization / Transmission of MDRO (Multi drug resistant organisms) P36

Interventions

Group 1: Hand Hygiene care policy in 2_MRGN colonized Infants (Term and Preterm) (Intervention): During 12 months, Infants colonized with 2_MRGN pos bacteria are nursed with normal Hand Hygiene care

Sponsors

UNIVERSITÄTSKLINIKUM WÜRZBURG, Kinderklinik und Poliklinik
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion of an entire neonatal unit. Analyses of microbiotic Screening-data, not Patient specific data

Exclusion criteria

Exclusion criteria: Exclusion of a Center in case of missing microbiotic surveillance (KRINKÒ)

Design outcomes

Primary

MeasureTime frame
Primary Endpoint is the rate of blood kulture pos. infections with gram neg. bacteria in all term- and preterm infants, in wich a Screening was performed (non- inferiority). This endpoint is defined clinically along NEO-KISS-criteria (two signs of Sepsis + one laboratory sign of Inflammation (e.g. CrP >10mg/dl) and proof of a gram neg. pathogen in bood culture)

Secondary

MeasureTime frame
Secondary endpoints are i.a. the transmission rate of 2_MRGN bacteria. Transmission is postulated if two children are colonized are infected with the same bacteria (with same resistance spectrum) in spaciotemporal connection. Other secondary endpoints are the transmissionrate of other bacteria included in the KRINKO-Screening, rate of all blood-stream infections and clinical infections, number of antibiotic cycles, use of antibiotics of the last resort (e.g. carbapenemes) and consumption rate of antibiotics and desinfectants.

Countries

Germany

Contacts

Public ContactKirstin Faust

Universität zu LübeckUniversitätsklinikum Schleswig Holstein, Campus LübeckKlinik für Kinder- und Jugendmedizin

kirstin.faust@uksh.de0451 500-42900

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026